# RouteOne

> RouteOne is a VC fund in Farmington Hills backing Biopharma and Life Science. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Farmington Hills, United States
- Total investments: 2
- Last investment: Mar 2021
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company-beta/20468/
- X (Twitter): https://twitter.com/routeone
- Website: https://www.routeone.com/
- Facebook: http://www.facebook.com/RouteOneLLC

RouteOne is a free web-based credit application management system created to streamline the F&I process for finance sources.

## Contacts

5 contacts available for RouteOne. Shizune tracks 3 team members at RouteOne. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/routeone?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 50% |
| Life Science | 1 | 50% |
| Therapeutics | 1 | 50% |
| Biotechnology | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Bill Duhamel | Managing Member | 1 | https://shizune.co/investors/profile/bill-duhamel-8d33 |
| Chris Irving | Chief Information Officer | 0 | https://shizune.co/investors/profile/chris-irving-38e2 |
| Justin Oesterle | CEO | 0 | https://shizune.co/investors/profile/justin-oesterle-de9b |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| OneSource | OneSource is a biopharmaceutical company that delivers affordable treatments to patients in both emerging and developed markets. It provides a one-stop-shop with comprehensive capabilities from cell line and process development through to scale up, cGMP manufacturing, and filling/finishing of proteins and peptides. Offer services at everystage of the development life cycle, from pre-clinical and clinical development to commercial Supply. At Stelis BioSource™, we assure customers of CDMO/CMO services our deep commitment to quality, service, and compliance. | $125M | Series C | Mar 19, 2021 |  |
| OneSource | OneSource is a biopharmaceutical company that delivers affordable treatments to patients in both emerging and developed markets. It provides a one-stop-shop with comprehensive capabilities from cell line and process development through to scale up, cGMP manufacturing, and filling/finishing of proteins and peptides. Offer services at everystage of the development life cycle, from pre-clinical and clinical development to commercial Supply. At Stelis BioSource™, we assure customers of CDMO/CMO services our deep commitment to quality, service, and compliance. | $125M | Series C | Mar 19, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [Mankekar Family Office](https://shizune.co/investors/profile/mankekar-family-office) — VC Fund, 4 deals together
- [TPG Growth](https://shizune.co/investors/profile/tpg-growth) — VC Fund, 4 deals together
- [GMS Holdings](https://shizune.co/investors/profile/gms-holdings) — VC Fund, 2 deals together
- [Think Investments](https://shizune.co/investors/profile/think-investments) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does RouteOne invest in?

RouteOne invests primarily in Biopharma, Life Science and Therapeutics startups, most often at Series C stage. Most of the 2 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact RouteOne?

Public channels for RouteOne include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at RouteOne?

The team at RouteOne includes Bill Duhamel (Managing Member), Chris Irving (Chief Information Officer) and Justin Oesterle (CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co